House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
House Rx has raised $55.0M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
House Rx's investors include Bessemer Venture Partners, Khosla Ventures, Town Hall Ventures, New Enterprise Associates, Maverick Ventures.
House Rx is headquartered in San Francisco, United States.
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
House Rx is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"House Rx — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/house-rx. Accessed October 17, 2026.
VCBacked. (2025). House Rx — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/house-rx
{{cite web |title=House Rx — Funding & Investors |url=https://www.vcbacked.co/company/house-rx |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated